Active, Not Recruiting
A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.Coli) in Chinese Males
NCT06866574
- Conditions
- Anal Cancer, Anal Intraepithelial Neoplasia, Anus Diseases, +34 more
- Locations
-
- Fujian Provincial Center for Disease Control and Prevention Fuzhou, Fujian, China
- Sichuan Provincial Center for Disease Control and Prevention Chengdu, Sichuan, China
- Yunnan Provincial Center for Disease Control and Prevention Kunming, Yunnan, China
- Zhejiang Provincial Center for Disease Control and Prevention Hangzhou, Zhejiang, China